Experienced in Ewing Sarcoma
Experienced in Ewing Sarcoma
1 Medical Center Drive, Dartmouth Hitchcock - Pediatrics, 
Lebanon, NH 
 (1703.5 mi)

Overview

Sara Chaffee is a Pediatric Hematologist Oncology provider in Lebanon, New Hampshire. Dr. Chaffee and is rated as an Experienced provider by MediFind in the treatment of Ewing Sarcoma. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Adult Soft Tissue Sarcoma, Osteosarcoma, Leukemia, and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 3 peer reviewed articles and participating in 39 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has participated in 5 clinical trials in the study of Ewing Sarcoma.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in NH
Languages Spoken
English
Gender
Female

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Humana

Locations

1 Medical Center Drive, Dartmouth Hitchcock - Pediatrics, Lebanon, NH 03756

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


39 Clinical Trials

Renal Tumors Classification, Biology, and Banking Study
Neuroblastoma Biology Studies
Umbrella Long-Term Follow-Up Protocol
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
View 33 Less Clinical Trials
Similar Doctors
Advanced in Ewing Sarcoma
Pediatric Hematology Oncology | Pediatrics
Advanced in Ewing Sarcoma
Pediatric Hematology Oncology | Pediatrics
1 Medical Center Dr, 
Lebanon, NH 
 (0.2 mi)
Languages Spoken:
English
Offers Telehealth

Nadine Santacruz is a Pediatric Hematologist Oncology specialist and a Pediatrics provider in Lebanon, New Hampshire. Dr. Santacruz and is rated as an Advanced provider by MediFind in the treatment of Ewing Sarcoma. Her top areas of expertise are Hepatoblastoma, Langerhans Cell Histiocytosis, Histiocytosis, Reticulohistiocytoma, and Bone Marrow Aspiration.

Experienced in Ewing Sarcoma
Pediatric Hematology Oncology | Pediatrics
Experienced in Ewing Sarcoma
Pediatric Hematology Oncology | Pediatrics
1 Medical Center Dr, Dhmc, Pediatric Hematology/oncology, 
Lebanon, NH 
 (0.2 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Julie Kim is a Pediatric Hematologist Oncology specialist and a Pediatrics provider in Lebanon, New Hampshire. Dr. Kim and is rated as an Experienced provider by MediFind in the treatment of Ewing Sarcoma. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Hepatoblastoma, Gliomatosis Cerebri, Histiocytosis, and Bone Marrow Aspiration. Dr. Kim is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile